1. Home
  2. MBIO vs BNBX Comparison

MBIO vs BNBX Comparison

Compare MBIO & BNBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.13

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Logo Applied DNA Sciences Inc.

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$1.51

Market Cap

5.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
MBIO
BNBX
Founded
2015
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MBIO
BNBX
Price
$1.13
$1.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
90.9K
266.5K
Earning Date
11-07-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,136,935.00
Revenue This Year
N/A
$253.12
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.11
52 Week Low
$0.89
$1.16
52 Week High
$13.29
$186.60

Technical Indicators

Market Signals
Indicator
MBIO
BNBX
Relative Strength Index (RSI) 49.66 N/A
Support Level $0.92 N/A
Resistance Level $1.15 N/A
Average True Range (ATR) 0.07 0.00
MACD 0.01 0.00
Stochastic Oscillator 86.99 0.00

Price Performance

Historical Comparison
MBIO
BNBX

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About BNBX Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: